Compounds > 2-naphthol
Page last updated: 2024-08-18

2-naphthol and Thrombosis

2-naphthol has been researched along with Thrombosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
OBRIST, F1
BONOW, A; GERL, D1
Akhmedov, A; Breitenstein, A; Camici, GG; Elliott, PJ; Holy, EW; Lohmann, C; Lüscher, TF; Matter, CM; Spescha, R; Stein, S; Tanner, FC; Westphal, CH1
Fukao, H; Hayashi, M; Horibuchi, K; Matsuno, H; Matsuo, O; Okada, K; Uematsu, T; Ueshima, S1
Schaub, RG; Yamashita, A1
Padar, E1

Other Studies

6 other study(ies) available for 2-naphthol and Thrombosis

ArticleYear
[Hemato-serological recognition of thrombosis hazard with special evaluation of the beta-naphthol test].
    Gynaecologia. International monthly review of obstetrics and gynecology. Revue internationale mensuelle d'obstetrique et de gynecologie. Monatsschrift fur Geburtshilfe und Gynakologie, 1957, Volume: 144, Issue:4

    Topics: Humans; Naphthalenes; Naphthols; Thromboembolism; Thrombosis

1957
[THE BETA-NAPHTHOL TEST AND ITS SIGNIFICANCE IN THE PREVENTION OF EMBOLISM].
    Zentralblatt fur Gynakologie, 1964, Jun-06, Volume: 86

    Topics: Blood Coagulation Tests; Embolism; Humans; Naphthalenes; Naphthols; Pulmonary Embolism; Thrombosis

1964
Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
    Cardiovascular research, 2011, Feb-01, Volume: 89, Issue:2

    Topics: Animals; Benzamides; Binding Sites; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activators; Genes, Reporter; Histone Deacetylase Inhibitors; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Naphthalenes; Naphthols; Promoter Regions, Genetic; Pyrones; Resveratrol; RNA Interference; RNA, Messenger; Sirtuin 1; Stilbenes; Thromboplastin; Thrombosis; Transcription Factor RelA; Transfection

2011
Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
    Thrombosis and haemostasis, 2002, Volume: 87, Issue:6

    Topics: Administration, Oral; Animals; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelium, Vascular; Femoral Artery; Fibrinolytic Agents; Hemostasis; Humans; Mice; Mice, Knockout; Naphthols; Pyrimidines; Rats; Rats, Sprague-Dawley; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Umbilical Veins; Venous Thrombosis

2002
Leukocyte mediated vein injury and thrombosis is reduced by a lipoxygenase inhibitor.
    Experimental and molecular pathology, 1986, Volume: 45, Issue:3

    Topics: Animals; Arachidonate Lipoxygenases; Cats; Cell Adhesion; Cell Movement; Endothelium; Jugular Veins; Leukocytes; Leukotriene B4; Lipoxygenase Inhibitors; Microscopy, Electron; Microscopy, Electron, Scanning; Naphthols; Neutrophils; Thrombosis; Thromboxane A2; Thromboxane B2

1986
Fibrin cross-linkage, thrombosis and pregnancy.
    Annals of the New York Academy of Sciences, 1972, Dec-08, Volume: 202

    Topics: Blood Coagulation; Chemical Precipitation; Drug Stability; Factor XIII; Female; Fibrin; Fibrinogen; Humans; Light; Naphthols; Pregnancy; Pregnancy Complications; Solubility; Thrombosis; Time Factors; Urea

1972